In the United States, someone develops Alzheimer’s every 66 seconds, and more than $5 million people are living with the disease. The cause is near and dear to our hearts: Leonard Astrup, who founded our family-owned company in 1952, battled the disease. On June 21st, our Sterling pharmacies joined together to recognize “The Longest Day”, an initiative to raise funds and awareness of Alzheimer's Disease with a day of activity.
Spending on Specialty drugs has nearly doubled in the past five years and has contributed to massive overall medicine spending growth. This week, Drug Channels’ Adam Fein released his analysis of the 2016 Specialty pharmacy estimates naming the largest players in the $115 billion-dollar market. He deftly points out one of the challenges felt by many independents who want to grow their own Specialty practices: many PBMs limit the ability of an independent to compete by requiring patients to use the pharmacies that the PBMs own, concentrating most of the business year-after-year with two players—ExpressScripts and CVS Health. Still, there is opportunity in Specialty, and it may well be a good way to diversify. Our own Sterling Specialty president, Tim Gallagher, had the opportunity to talk about pharmacy’s foray into the Specialty field, and spoke to a group of interested pharmacists at the NCPA Specialty Conference in New Orleans last October. Here’s the transcript, if you missed it.
Here are few other stories that might be of interest: